{'52WeekChange': -0.40029758,
 'SandP52WeekChange': None,
 'address1': '1555 Bayshore Highway',
 'address2': 'Suite 200',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 3.89,
 'askSize': 1100,
 'averageDailyVolume10Day': 202875,
 'averageVolume': 423604,
 'averageVolume10days': 202875,
 'beta': 1.02633,
 'beta3Year': None,
 'bid': 3.88,
 'bidSize': 4000,
 'bookValue': 1.544,
 'category': None,
 'circulatingSupply': None,
 'city': 'Burlingame',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 4.03,
 'dayLow': 3.856,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -1.886,
 'enterpriseToRevenue': 27.961,
 'enterpriseValue': 121464744,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 4.2757144,
 'fiftyTwoWeekHigh': 11.93,
 'fiftyTwoWeekLow': 3.105,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 30272262,
 'forwardEps': -1.02,
 'forwardPE': -3.8039217,
 'fromCurrency': None,
 'fullTimeEmployees': 156,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.05957,
 'heldPercentInstitutions': 0.67656,
 'industry': 'Drug Manufacturers—Specialty & Generic',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/kindredbio.com',
 'longBusinessSummary': 'Kindred Biosciences, Inc., a biopharmaceutical '
                        'company, is developing biologics that focus on the '
                        'lives of pets. The company has a pipeline of novel '
                        'biologics in development across various therapeutic '
                        'classes and intellectual property portfolio. Its '
                        'programs under development include interleukin-31 and '
                        'interleukin-4R for canine atopic dermatitis; KIND-030 '
                        'for parvovirus in dogs; KIND-510a for the control of '
                        'non-regenerative anemia in cats; anti-TNF antibody '
                        'for inflammatory bowel disease in dogs; and other '
                        'biologics candidates. The company was founded in 2012 '
                        'and is headquartered in Burlingame, California.',
 'longName': 'Kindred Biosciences, Inc.',
 'market': 'us_market',
 'marketCap': 152443648,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_224401923',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -68095000,
 'nextFiscalYearEnd': 1640908800,
 'open': 4.01,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.08,
 'phone': '650-701-7901',
 'previousClose': 4.03,
 'priceHint': 4,
 'priceToBook': 2.5129533,
 'priceToSalesTrailing12Months': 35.092922,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 4.03,
 'regularMarketDayLow': 3.856,
 'regularMarketOpen': 4.01,
 'regularMarketPreviousClose': 4.03,
 'regularMarketPrice': 4.01,
 'regularMarketVolume': 115338,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 39289600,
 'sharesPercentSharesOut': 0.0127,
 'sharesShort': 497971,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 514577,
 'shortName': 'Kindred Biosciences, Inc.',
 'shortPercentOfFloat': 0.0165,
 'shortRatio': 0.87,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'KIN',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.746,
 'twoHundredDayAverage': 6.118993,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'a0f6b4bd-5882-3328-8004-371feb0b9ce0',
 'volume': 115338,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.kindredbio.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '94010'}